102 related articles for article (PubMed ID: 9814952)
1. Maturation of immune responses to lentivirus infection: implications for AIDS vaccine development.
Montelaro RC; Cole KS; Hammond SA
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S255-9. PubMed ID: 9814952
[TBL] [Abstract][Full Text] [Related]
2. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
Hammond SA; Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
[TBL] [Abstract][Full Text] [Related]
4. Virus-like particles: designing an effective AIDS vaccine.
Young KR; McBurney SP; Karkhanis LU; Ross TM
Methods; 2006 Sep; 40(1):98-117. PubMed ID: 16997718
[TBL] [Abstract][Full Text] [Related]
5. Biological considerations in the development of a human immunodeficiency virus vaccine.
Nathanson N; Mathieson BJ
J Infect Dis; 2000 Aug; 182(2):579-89. PubMed ID: 10915092
[TBL] [Abstract][Full Text] [Related]
6. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
[TBL] [Abstract][Full Text] [Related]
7. New gene-based approaches for an AIDS vaccine.
Puaux AL; Michel ML
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
9. Candidate vaccines protect macaques against primate immunodeficiency viruses.
Stott J; Hu SL; Almond N
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
[TBL] [Abstract][Full Text] [Related]
10. Mucosal responses to parenteral and mucosal vaccines.
Kaul D; Ogra PL
Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424
[TBL] [Abstract][Full Text] [Related]
11. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
12. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
13. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
14. Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting.
Bull World Health Organ; 1987; 65(4):453-63. PubMed ID: 3319268
[TBL] [Abstract][Full Text] [Related]
15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.
Calarota SA; Weiner DB
Immunol Rev; 2004 Jun; 199():84-99. PubMed ID: 15233728
[TBL] [Abstract][Full Text] [Related]
17. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost strategies in DNA vaccines.
Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
[TBL] [Abstract][Full Text] [Related]
19. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
20. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
